Ophthalmic Lasers Market Regional Trend & Growth Projections 2027
                     Ophthalmic Lasers Market To 
Reach USD 1.55 Billion By 2026 | 
Abbott Medical Optics, Johnson 
and Johnson, Alcon Laboratories 
www.reportsanddat
a.com
       Market  Summary
Increased incidence of ocular disorders, rising 
occurrence of chronic disorders, continuous 
authorizations and approvals and favorable 
initiatives to minimize vision impairment are key 
factors contributing to high CAGR of ophthalmic 
lasers market during the forecast period.
Market Size – USD 1.05 Billion in 2018, Market 
Growth - CAGR of 4.9%, Market Trends– The advent 
of femtosecond lasers and recent technical 
innovations in ophthalmic lasers.
            M  a Orkuetr  S Aumpmparroyach
The global ophthalmic lasers market was valued at USD 1.05 billion by the year 2018 and is expected to reach USD 
1.55 billion in the year 2026, at a CAGR of 4.9%. Lasers have become a factor of a necessity for ophthalmologists. 
These provide proper treatment of various eye disorders with fewer chances of infection. The lasers depend on the 
radioactive material; it cures diabetic retinopathy as the blue, green wavelengths are formed, and the cells absorb 
the wavelengths below the retina and the hemoglobin itself. It avoids the leakage caused in the blood vessels. 
Retinal photocoagulation is the first clinical laser application. According to the recent survey conducted, around 285 
million people are visually blind. 43% of the population have refractive errors, and 51% (including the 50 above 
population) suffer from cataract. Latest therapies in the market involves the scatter laser treatment, used to cure 
the slow progression of diabetic retinopathy and also in patients suffering from the successive loss of vision with 
non-high risk Proliferative Diabetic Retinopathy and Non-proliferative Diabetic Retinopathy.
The drivers responsible for the growth of the ophthalmic laser market is the increased population incidence of eye 
disorders, the rise in obese and geriatric population, maximum capabilities to bring visual impairment under 
control, upcoming technological innovations and legal approvals for ophthalmic lasers.
Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/2519
       M   a r kOeut  Sru Ampmparyoach
Further key findings from the report suggest
• North America had obtained a market share of 34.5% and a market revenue of USD 361.2 in 2018. 
Increased incidence of chronic diseases, high occurrence of eye disorders, and continuous 
registration and approvals.
• According to the forecast period, the femtosecond lasers is planning to reach USD 691.6 million by 
2026 due to the widespread presence of refractive errors and cataract, increasing the administered 
use of femtosecond lasers and technological innovations in the lasers itself.
• The hospital segment is going to project the largest share of the market due to new forefront 
technology in machines and devices and progressive growth of hospitals in upcoming segments.
• Asia Pacific is bound to show positive growth with a CAGR of 6.0% in 2026 due to the sudden 
increase in optic diseases, advancements in projects related to treatment. 
To identify the key trends in the industry, click on the link below @ 
https://www.reportsanddata.com/report-detail/ophthalmic-lasers-market
       M   a r kOeut  Sru Ampmparyoach
Key participants :  Abbott Medical Optics, Inc., Johnson and Johnson (USA), Alcon Laboratories 
(Switzerland), Bausch and Lomb (United States), Ellex Medical Lasers Limited (Australia), Lumenis Ltd., 
Nidek Company (Japan) and IRIDEX Corporation (U.S.), Carl Zeiss Meditec, Ziemer.
For the purpose of this report, Reports and Data has segmented the ophthalmic lasers market on the 
basis of products, application, end use and region wise segmentation.
Product Outlook (Revenue in Million USD; 2016–2026)
Diode lasers
Excimer lasers
Femtosecond lasers
Nd: YAG lasers
Others
        M  a  rOkeut  rSu Ampmparyoach
Application Outlook (Revenue in Million USD; 2016–2026)       
Age related macular degeneration treatment
Cataract treatment
Glaucoma treatment
Refractive eye surgery
Diabetic Retinopathy Treatment
Other Applications
End Use Outlook (Revenue in Million USD; 2016–2026)
Hospital
Eye clinics
Ambulatory surgery centers
Order Now @ https://www.reportsanddata.com/checkout-form/2519
About Us
   A  b  oOuutr U Aspproach
Reports and Data is a market research and consulting company that provides syndicated research reports, 
customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, 
target and analyze consumer behavior shifts across demographics, across industries and help client’s make a 
smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across 
a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our 
research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and 
Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]